Publication | Closed Access

A Th1 cytokine–enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells

Activated T CellsTumor ImmunologyMicroenvironment Enhances TumorCancer ImmunosurveillanceImmunologyTumor ImmunityT Cell ImmunityImmunotherapeuticsCd4 T Cell ResponsesCell BiologyCellular Immune ResponseImmunotherapyMedicineCell TransplantationTumor MicroenvironmentTumor BiologyBispecific Antibodies